Covaxin of Bharat Biotech

COVAXIN

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against the Delta variant. In a pre-print paper that is yet to be peer-reviewed, the company claimed that the vaccine is also 63 per cent effective …

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals Read More »

Covid vaccine manufacturers SII and Bharat Biotech get financial assistance from government to ramp up vaccine production

Union Finance Minister has approved a total of Rupees 4,567.50 crore as advance payment to Covishield and Covaxin manufacturers Serum Institute of India (SII) and Bharat Biotech to ramp up production against coronavirus. The government has approved Rupees 3,000 crore financial assistance to SII and Rupees 1567.50 crore to Bharat Biotech which will soon be …

Covid vaccine manufacturers SII and Bharat Biotech get financial assistance from government to ramp up vaccine production Read More »